# Tools for Following Cells and Genes

> Developmental neuroscience is a methods field: almost every idea in it rests on a way of marking a cell, dating it, following its descendants, or removing a gene from it. This lesson sorts the toolkit by the question each tool answers, then walks through how a mouse is built to order, including the genotype notation you will meet in papers. Afterwards you can match a method to a question and say what a result does and does not show.

Course: Developmental Neuroscience (The problem and the tools). Level: advanced university and graduate. About 21 minutes.
Lesson page (link this one when citing): https://stemhop.com/lessons/tools-for-development/

Builds on: The Wiring Problem: How a Brain Gets Built · Seeing Neurons: Golgi, Cajal and the Neuron Doctrine

## What you'll learn

- Match a labeling, tracing or birth-dating method to the question it can answer.
- Explain how a lineage is followed, from grafted quail cells to Cre-dependent reporters.
- Build a conditional mouse on paper and read a genotype such as AvilCre/+;TrkAfl/-.
- Distinguish necessary from sufficient, and a reporter from an actuator.

**A neuron carries no label saying when it was born, which cell it descends from, or which genes it needs.** Developmental neuroscientists make those hidden histories readable, then ask only what the mark can justify.

> **The guiding idea.** Within the methods here, the event a tool records or changes sets the strongest claim it can support: protein binding reports detection of a molecular target, transport reports a projection, DNA synthesis approximately dates a cohort, inherited DNA change reports ancestry, deletion tests necessity, and imposed activity tests sufficiency.
>
> *Scope:* this rule chooses and interprets the methods in this lesson. “Strongest claim” means the direct claim under the tested conditions, not a complete account of the biology.

| Question | Event carrying the information | Strongest direct claim |
| --- | --- | --- |
| What is the cell? | A stain or antibody binds its target | The target was detected there |
| Where does it project? | A tracer is transported along an axon | Labelled cells project to, or labelled terminals arise from, the injected region at population scale |
| When did it stop dividing? | Label enters DNA during synthesis, then dilutes with division | Heavy residual label approximately dates the last S phase |
| Whose descendant is it? | A durable mark passes to daughter cells | Marked cells descend from the marked founder or population |
| What does a gene or activity do? | An intervention removes or imposes it | The outcome tests necessity or sufficiency under those conditions |

## What is this cell, and where does it connect?

Three staining strategies, three uses. A [Nissl stain](https://stemhop.com/methods/histology-and-stains/) binds the RNA-rich cytoplasm around a nucleus, so it shows cell bodies across a section, along with glial nuclei and some proximal dendrite: good for counting cells and finding the boundaries of layers. A [Golgi stain](https://stemhop.com/methods/golgi-stain/) fills a small, unpredictable fraction of cells completely, including their dendrites, so you see the whole shape of a few neurons against a clear background. [Immunostaining](https://stemhop.com/methods/immunohistochemistry/) uses an antibody against one chosen protein, so it reports whether that molecular target was detected. The cost is specificity in the other direction: an antibody raised against a mouse protein may not recognize the chick version, and a monoclonal antibody that sees one site can fail when that site is masked. The logic of antibodies as detection reagents is covered in [detecting a signal](https://stemhop.com/lessons/detecting-a-signal/).

Connections use the neuron’s transport machinery. Inject an [anterograde tracer](https://stemhop.com/methods/neuronal-tract-tracing/) such as biotinylated dextran amine into a region; neurons there carry it toward their terminals, reporting where those cells project. Cholera toxin B subunit travels both ways and is used mainly retrogradely, so direction must be established for each tracer. Inject Fluorogold into a target instead, and terminals carry it back to cell bodies. That labels neurons whose terminals take up enough tracer there. Either dye injection gives population wiring, not one cell’s synapses. Genetically targeted viruses go further: a rabies virus restricted to one synaptic step labels cells directly presynaptic to a defined starter population, or even one starter cell.

**Predict.** An antibody gives no signal in a chick section, although it detects the mouse version of the protein. Does the negative result prove that chick cells lack the protein?

> **Check your prediction.** No. The antibody may not recognize the chick version, or its single recognized site may be masked. A negative detection result is not automatically evidence that the target is absent.

*Figure (AI-generated illustration).* Fluorogold injected into a target region is taken up by axon terminals and transported back to cell bodies, labeling neurons whose terminals take up enough tracer there. Not every projecting neuron is necessarily labeled. This dye injection maps population projections, not individual synapses. Image: a dye injected into a target region is taken up by axon terminals and carried back along three axons to light up their cell bodies, while a neighbouring neuron that projects elsewhere stays unlabeled.

## When was this cell born?

[Tritiated thymidine](https://stemhop.com/methods/thymidine-analog-birthdating/), and later the thymidine analog BrdU, use DNA replication as a clock. They are incorporated wherever DNA is being synthesized, which in a dividing cell means S phase. Give a pulse, wait through a **chase**, and look for label.

**Predict.** A BrdU-positive nucleus appears in injured tissue whose cells are thought to be non-dividing. Must that cell have passed through S phase?

> **Check your prediction.** No. Thymidine analogues can also enter DNA during repair. In a dividing cell the main interpretation is S phase, but BrdU alone does not distinguish repair from replication in injured tissue. Cell-cycle evidence and the experimental context are needed.

After a pulse in proliferating tissue, each further division usually dilutes label among descendants. Heavy residual label supports few additional divisions; weak label is consistent with continued cycling, although uptake and detection also vary. The inferred “birthday” is therefore an approximate last S phase, not an exact timestamp or a readout of cell identity.

The main model has now done its work. The human cases and their limits are in Going deeper.

## Whose descendant is this cell?

A birth date marks a cohort; a lineage is a family. Classical methods lead to modern multicolour reporters and genetic barcodes that separate one founder’s family from its neighbours. Reconstructing somatic mutations is the main route to lineage in the human brain.

[Grafting](https://stemhop.com/methods/tissue-grafting-and-transplantation/) with a nuclear marker is the classic approach. Quail nuclei carry a distinctive condensed-chromatin pattern, so quail cells grafted into a chick embryo stay recognizable in sections after they migrate and differentiate. Le Douarin built an experimental program on that difference, following grafted populations into ganglia, gut and head mesenchyme.

Retroviral labeling works inside one animal. A retrovirus integrates its genome into the DNA of a dividing cell, so every descendant of that cell inherits the insert and the marker gene it carries. Keep the dose low enough that labeled clones do not overlap, and a cluster of marked cells is one progenitor’s family. That assumption is a sampling argument, not an observation, and it is where this method can fail.

The genetic version is the one you will use. A Cre-dependent reporter commonly places a loxP-flanked transcriptional stop before a [fluorescent protein](https://stemhop.com/methods/fluorescent-protein-tagging/) gene; other designs leave the gene inverted until Cre flips it. When [Cre recombinase](https://stemhop.com/methods/cre-lox/) deletes the stop, the recombined allele passes to descendants. They stay labelled as long as the reporter’s promoter is active. The DNA marking is permanent and heritable through division.

**Predict.** Quail-derived cells later appear in a chick peripheral ganglion. Does the marker show that the host contributed no ganglion cells?

> **Check your prediction.** No. The marker shows that the marked cells descend from the graft. Unmarked host cells may also contribute, and the graft does not by itself reveal which signals were required or the potential of any single founder. Reporters and actuators themselves are taught in [hacking the cell](https://stemhop.com/lessons/hacking-the-cell/); here the point is recombination.

A cell-type Cre that recombines many founders with one colour gives a population [fate map](https://stemhop.com/methods/lineage-tracing/), not separate clones. Following one family requires sparse or low-dose induction, multicolour reporters, or founder-specific barcodes.

The same logic can now change a gene rather than merely preserve a history.

**Film transcript: Build a Conditional Test**

### Film transcript: Build a Conditional Test

Chapter one asked what a label can prove. How can we test what a gene does in one cell type, after birth? We need to control three things: the target, the place, and the time. First, build the target. Place loxP sites around an important gene segment. This floxed allele is designed to work normally until Cre recombinase removes that segment. A Cre-free control must test whether the allele really does work normally. Next, control the place. A cell-type promoter supplies Cre only where that driver is active. Cre deletes the bracketed segment largely in those cells. But a driver's actual range and completeness must be measured, not assumed from its name.

Then control the time. CreER is designed to keep Cre outside the nucleus until tamoxifen is given. A gold time gate opens after birth. Recombination is concentrated after dosing, but its actual timing must be measured. Now read the cross one locus at a time. AvilCre/+ supplies one Cre driver allele.

TrkAfl/− supplies one floxed allele and one null allele. The semicolon joins the two instructions in one mouse. A matched control changes one causal piece. Keep the floxed and null TrkA alleles, but remove Cre. That mouse preserves the target genotype without triggering deletion. A second control can retain Cre while keeping one working TrkA copy. Now predict carefully. A cell glows green from a Cre-dependent reporter. Does that glow prove the separate floxed target gene was deleted?

No. The reporter and target are separate lox-flanked loci, and they can recombine differently. Old target protein can also persist after deletion. Reporter light shows reporter recombination. Measure the target protein itself in those cells. Only then interpret the outcome. Removing a gene tests whether it is necessary under those conditions. Imposing activity with an actuator tests whether activity is sufficient. A reporter observes a state; it does not impose that state. A conditional experiment is a chain. Match the genotype to the perturbation, the perturbation to the measured readout, and the readout to the claim. Check every link with a control in practice.

One weak link limits the conclusion.

From the film

- Cre changes a floxed allele only where recombination occurs.
- An inducible driver adds control over timing.
- Read each locus separately before interpreting a cross.
- Reporter light does not prove target-gene deletion.

The second film began with a floxed allele; what it did not show is how that engineered allele reaches a mouse or what a real driver name can hide.

## How to make a mouse

To ask what a gene does, change it. In the classical route, mouse embryonic stem cells from an early embryo can still contribute to any tissue of the body, including the germ line. Supply DNA matching the target gene on both sides of an intended change. In rare cells, homologous recombination swaps the new version into the gene’s own place.

Because targeting is rare, select twice. A positive marker inside the construct retains cells that took up DNA. A negative marker outside the matching arms, classically a thymidine kinase gene that makes ganciclovir lethal, kills most cells that inserted the whole construct randomly and kept that marker. Survivors still require genotyping. Destroying a gene is a **knockout**; writing in a sequence such as a fluorescent reporter is a **knock-in**. Selected cells enter an early embryo. The pup is a chimera, and the allele is heritable if those cells made its gametes.

*Figure (AI-generated illustration).* Positive selection retains mouse embryonic stem cells expressing the positive marker. Correct homologous replacement places that marker at the target locus while excluding the thymidine kinase gene, which lies outside the homology arms on the targeting construct. Ganciclovir kills most random integrants that retain functional thymidine kinase. Some random integrants escape negative selection, so surviving clones must still be genotyped. Image: a continuous gene-targeting DNA construct has two homology arms flanking a positive marker, with a thymidine kinase gene connected beyond the right arm. Below, a correctly targeted mouse embryonic stem cell lacks the thymidine kinase gene and survives both selections; a representative random integrant retains it and is killed by ganciclovir. Random integrants can escape selection, so surviving clones require genotyping.

A straight knockout can kill an embryo before the question matters, and whole-body deletion cannot identify the tissue that mattered. The loxP sites introduced in the film are each 34 base pairs long. A doxycycline-driven tetracycline-controlled system provides an alternative to [CreER](https://stemhop.com/methods/cre-lox/) for timing.

Keep the reminder short: **the changed event limits the claim**. A superscript names what is written at a locus; a slash separates its alleles. Thus p75NTR-/- is a homozygous knockout, DR6+/- a heterozygote, and p75NTR-/-;TNFR1-/- a double knockout.

Now go beyond the chapter’s notation. In **AvilCre/+;TrkAfl/-**, Advillin controls the Cre allele. This driver has long been used for sensory neurons, but advillin and Avil-Cre recombination also occur in sympathetic, parasympathetic and enteric neurons. The floxed TrkA copy is the only potentially functional copy available to lose. The genotype therefore deletes TrkA wherever this Avil-Cre is active, including sensory and some autonomic neurons.

**Predict.** The full CreER, floxed-gene and reporter genotype receives vehicle instead of tamoxifen. Which failure does that control test?

> **Check your prediction.** It tests ligand-independent CreER activity: recombination when the inducing drug was withheld. A Cre-negative TrkAfl/- littermate instead preserves the floxed and null alleles without Cre. AvilCre/+;TrkAfl/+ retains a wild-type TrkA copy and is a further control for Cre activity itself.

The schematic cannot tell how often a real driver is leaky, recombining where or when it should not, or mosaic, recombining in only some target cells. Nor can reporter light quantify residual target protein. Measure the driver’s range and the target’s loss in the tissue, ages and animals used.

Intersectional targeting adds a second recombinase, Flp, with its own sites and runs two independent switches. Requiring both switches in the same cell increases specificity.

*Interactive on the lesson page:* Conditional mouse builder: where does Cre act?

### Design problem

Gene X is needed for the embryo to survive, so a straight knockout dies before birth. You want to know what X does in sensory neurons after birth. Design the mouse: list the alleles, the drug, the reporter, and three controls.

> **One way to do it.** Alleles: a sensory-neuron CreER driver, such as an Advillin-CreER line; X floxed over floxed; and a Cre-dependent fluorescent reporter. Map recombination in autonomic ganglia too, because advillin is not sensory-specific after birth. Give tamoxifen after birth to preserve X through embryonic development and trigger deletion later; the vehicle control tests whether ligand-independent recombination undermines that timing. The reporter marks cells in which Cre was active.
>
> Three controls: CreER with no floxed allele, given tamoxifen, tests whether Cre plus tamoxifen harms neurons by itself. Floxed over floxed with no CreER, given tamoxifen, tests whether the floxed allele is hypomorphic, or partly defective without Cre. The full experimental genotype given vehicle tests ligand-independent CreER activity. In the same animals, measure how much X protein is actually gone in reporter-positive cells, because phenotype size depends on it.

## Necessary, sufficient, reporter, actuator

Two pairs of words now finish the experimental logic.

The first pair is about inference. **Sufficient** means you added the thing and the outcome followed. **Necessary** means you removed it and the outcome failed. Each can hold without the other.

**Predict.** Overexpressing protein A makes structure B expand, but knocking out A leaves B unchanged. Is A necessary, sufficient under the tested conditions, both, or neither?

> **Check your prediction.** A is sufficient under those conditions but not necessary for this outcome. The gain-of-function may place A at levels or locations it never normally reaches, or a redundant relative may cover its loss. The reverse pattern—necessity without sufficiency—would mean A is one requirement among several.

A **reporter** reads out a state: a [fluorescent protein](https://stemhop.com/methods/fluorescent-protein-tagging/) marks where a cell is, a tagged protein shows where it sits, and a calcium sensor brightens when calcium rises. An **actuator** imposes a state. Blue light opens [channelrhodopsin](https://stemhop.com/methods/optogenetics/), a cation channel, to drive firing; yellow light drives halorhodopsin to move chloride and suppress activity. Light-gated channels are introduced in [ion channels as receptors](https://stemhop.com/lessons/ion-channels-as-receptors/).

Chemical actuators use the same logic. Put transient receptor potential vanilloid 1 (TRPV1), a capsaicin-gated channel, into chosen neurons of a mouse whose own TRPV1 is knocked out; capsaicin then activates those neurons and not the rest. An activity reporter alone shows that activity goes with an outcome, not that it caused it. An actuator can ask whether that activity is enough.

## Going deeper

### Human birth-dating

Giving a [thymidine analog](https://stemhop.com/methods/thymidine-analog-birthdating/) to people only to study the brain is not done. The classic exception, Eriksson and colleagues in 1998, used postmortem tissue from patients already treated with BrdU during cancer care. For humans generally, atmospheric nuclear weapons testing raised carbon-14 sharply before the 1963 test ban treaty, after which it fell. A cell’s genomic-DNA carbon-14 therefore reflects the year its DNA was last made. Spalding and colleagues described matching genomic-DNA carbon-14 to the atmospheric record in 2005. The method is the point here; findings about turnover in particular human brain regions are contested and belong to adult neurogenesis.

### From classical targeting to newer routes

Capecchi’s laboratory, together with Smithies’s and Evans’s, established classical [gene targeting](https://stemhop.com/methods/gene-targeting-mice/). [CRISPR](https://stemhop.com/methods/crispr/) shortened that path: a guide RNA brings Cas9 nuclease to a matching sequence in a fertilized egg, so many alleles can now be built without stem cells or chimeras.

---

From STEMhop (https://stemhop.com), free lessons by Christopher Deppmann. Lesson text © the authors. Practice questions: https://stemhop.com/lessons/tools-for-development/
